The evaluation of efficacy of Avonex in the treatment of Multiple sclerosis patients in Tohid Hospital in Sanandaj

The effect of beta INF on multiple sclerosis has been reviewed in some studies but it is partially effective and some of its complications are unknown. This study was performed to evaluate Avonex efficacy in reducing relaps and attacks in the patients with Multiple sclerosis in Sanandaj. This was a before-after study from 1380 to 1382, encompassing 42 patients with multiple sclerosis who had received Avonex for 3 years. Data collected, were analyzed by means of SPSS. Win, x² and paired T-tests. Mean age of the patients was 34.85±13.73 years and most patients (42.8%) were between 30-39 years of age. 83.4% of patients were female and 16.6% of them were male (ratio5/1). The mean number of attacks in the patients before treatment with Avonex was 1.8±1.29, while after treatment it declined to 0.71±1.04. which is statistically significant (p<0.01). Results of this study suggest that Avonex reduce recurrences and attacks of MS in the patients.